Translational Research Institute
The University of Queensland (UQ) is a key partner in the Translational Research Institute (TRI). TRI is a unique, Australian-first initiative designed to more rapidly translate medical research from the ‘bench to the bedside’. TRI has the capacity to discover, produce, test and manufacture new treatments and vaccines in one location.
The $354M Translational Research Institute is the largest medical research facility of its kind in the southern hemisphere. It was made possible through funding from the Australian and Queensland Governments, The Atlantic Philanthropies, The University of Queensland and Queensland University of Technology.
TRI is comprised of three key partner organisations including the Queensland University of Technology’s Institute of Health and Biomedical Innovation, the Princess Alexandra Hospital Centres for Health Research and The University of Queensland.
The state-of-the-art building includes four floors of laboratory research plus facilities for research support, administration and teaching. A bio-pharmaceutical manufacturing facility
led by Patheon is situated adjacent to TRI and is equipped with cutting-edge technical and economical methods for producing clinical grade biopharmaceutical compounds.